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Abstract
Introduction
While chest x-rays (CXRs) represent a cost-effective imaging modality for developing countries like Pakistan, their utility for the prognostication of COVID-19 has been minimally
explored. Thus, we describe the frequency and distribution of CXR findings, and their association with clinical outcomes of patients with COVID-19.

Methods
All adult (� 18 years) patients presenting between 28th February-31st May to the emergency
department of a tertiary care hospital in Pakistan, who were COVID-19 positive on RT-PCR
with CXR done on presentation, were included. A CXR Severity Score (CXR-SS) of 0–8
was used to quantify the extent of pulmonary infection on CXR, with a score of 0 being negative and 1–8 being positive. The patients’ initial CXR-SS and their highest CXR-SS over the
hospital course were used for analysis, with cut-offs of 0–4 and 5–8 being used to assess
association with clinical outcomes.

Results
A total of 150 patients, with 76.7% males and mean age 56.1 years, were included in this
study. Initial CXR was positive in 80% of patients, and 30.7% of patients had an initial CXRSS between 5–8. The mortality rate was 16.7% and 30.6% patients underwent ICU admission with intubation (ICU-Int). On multivariable analysis, initial CXR-SS (1.355 [1.136–
1.616]) and highest CXR-SS (1.390 [1.143–1.690]) were predictors of ICU-Int, and ICU-Int
was independently associated with both initial CXR-SS 5–8 (2.532 [1.109–5.782]) and
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highest CXR-SS 5–8 (3.386 [1.405–8.159]). Lastly, age (1.060 [1.009–1.113]), initial CXRSS (1.278 [1.010–1.617]) and ICU-Int (5.047 [1.731–14.710]), were found to be independent predictors of mortality in our patients.

Conclusion
In a resource-constrained country like Pakistan, CXRs may have valuable prognostic utility
in predicting ICU admission and mortality. Additional research with larger patient samples is
needed to further explore the association of CXR findings with clinical outcomes.

Competing interests: The authors have declared
that no competing interests exist.

Introduction
With the outbreak of an unknown pneumonia in Wuhan, China, in December 2019, a new
human coronavirus, SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2), roused
the attention of the entire world. COVID-19 (coronavirus disease 2019), the potentially fatal
disease caused by SARS-CoV-2, was declared a pandemic by the World Health Organization
in March 2020 [1].
As the pandemic unfolds, healthcare systems worldwide continually seek to determine the
role of imaging in the diagnostics, management, and prognostication of COVID-19. The use
of ultrasound (US) has been explored previously in the diagnostics of other infectious diseases
[2]. Some studies have considered the emerging role of portable US imaging of the lungs in
COVID-19 detection, describing ultrasound findings such as B-lines, consolidation and thickened pleural lines [3]. However, US has its limitations, as it is highly operator-dependent and
difficult to perform in patients with severe disease in an intensive care unit (ICU) set-up.
Moreover, the specificity of ultrasound in patients with COVID-19 presenting with early disease has also proven to be significantly lower as compared to chest x-ray and computerized
tomography scans [4]. The utility of CT (computerized tomography) scans for COVID-19
imaging is being extensively explored [5]. However, the sheer influx of suspected and confirmed COVID-19 cases presenting to hospitals means that there is a major burden on radiology departments, posing immense challenges for infection control in the CT suite. The
American College of Radiology notes that CT decontamination required after scanning
patients with COVID-19 may disrupt radiological service availability, and suggests that portable chest x-ray (CXR) may be considered to minimize the risk of cross-infection [6].
Additionally, while CT scans have a good sensitivity in detecting subtle changes due to
COVID-19, their cost and other practical considerations limit their utility in developing countries such as Pakistan [7–9]. In Pakistan, the number of confirmed COVID-19 cases has
crossed 395,000 as of 29th November 2020, and the country is entering a second wave of
COVID-19 infections [10]. At the Aga Khan University Hospital, a tertiary care hospital in
Pakistan, patients presenting to the emergency department (ED) with COVID-19 symptoms
are assessed with a baseline set of investigations that include RT-PCR (reverse transcriptase
polymerase chain reaction) and CXR. Plain film radiography of the chest (CXR) is relatively
inexpensive and is widely available as an imaging modality in the smaller healthcare centers of
Pakistan. Though the radiographic features of CXRs in patients with COVID-19 have been
described [11], there is a scarcity of literature discussing the association of CXR findings with
clinical outcomes, particularly in our setting. Thus, in this article we aim to describe our experience of CXR imaging in patients with COVID-19, and explore the association between CXR
findings and clinical outcomes.
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Materials and methods
Setting and sample selection
This retrospective study was conducted between 28th February-31st May 2020 at the Aga Khan
University Hospital, a tertiary care hospital in Pakistan. For this retrospective study, ethical
approval was obtained from the institutional review board of the Aga Khan University Hospital (Reference Number: 2020-4774-10611). We were granted a waiver of informed consent as
this was a retrospective study and all patients were discharged from the hospital. No personal
identifiers were included in data collection, and records were anonymized to the statistician.
Adult patients (� 18 years) of either sex who presented to the emergency department with suspected COVID-19 based on clinical symptoms (fever, dry cough, dyspnea etc.), travel history,
or positive RT-PCR (reverse transcriptase polymerase chain reaction), were considered for
inclusion. Patients were enrolled if they were positive for COVID-19 based on RT-PCR and
underwent CXRs. Any patient with a known history of any other pulmonary infection, or who
was already admitted to the hospital due to some other disease, was excluded from the study.

Data collection
Patients’ data collected included clinical data accessed through the online patient care records
and radiographic data as follows:
• Clinical Data: These included demographics and pre-existing comorbids (diabetes, hypertension, chronic kidney disease, malignancy, etc.) for all patients. For inpatients, additional
variables included intensive care unit (ICU) admission with intubation (ICU-Int), hospital
outcome (mortality vs. healthy on discharge/left against medical advice/discharged on
request), and hospital length of stay (LOS).
• Radiographic Data: Two senior radiologists, with experience of more than 8 years in chest
imaging, reviewed the initial and follow-up CXRs of all patients in the study. In cases of disagreement, further review by a third radiologist, who had more than 10 years of experience,
was obtained. Radiographic features described through consensus of the radiologists
included laterality, centrality, zonal location, and type of infiltrates. All radiologists were
blinded as to the diagnosis and current clinical condition of the patient.

Radiograph severity scoring
For quantitative measurement of extent of pulmonary involvement, a CXR Severity Score
(CXR-SS) was calculated by adapting and simplifying the Radiographic Assessment of Lung
Edema (RALE) score proposed by Warren et al. [12]. A score of 0–4 was assigned to each lung
depending on the extent of involvement by consolidation or alveolar/interstitial infiltrates
(0 = no involvement; 1 = <25%; 2 = 25–50%; 3 = 50–75%; 4 = >75% involvement). The scores
for each lung will be summed to produce the final CXR-SS out of a maximum of 8 (11). An
example of the application of this scoring system is shown in Fig 1. A total score of 0 was considered as negative, while any score from 1–8 was considered as positive. This CXR Severity
Score has been used before to quantify the extent of pulmonary infection in COVID-19 [11].
We adopted this scoring system to evaluate its prognostic value for clinical outcomes of
COVID-19 in our setting. For the purpose of analysis, we used the patients’ initial CXR-SS and
highest CXR-SS. The initial CXR-SS was the score given to the patients’ first CXR upon presentation to the hospital. The highest CXR-SS was the score with the greatest value amongst all
the CXRs of a patient during their hospital course, which included both initial and subsequent
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Fig 1. CXR patterns. A) left lower zone consolidation; B) bilateral lower zone interstitial infiltrates; F) scattered alveolar infiltrates in right lung; H) bilateral
diffuse consolidation. CXR Severity Scoring (Right + Left): (A) 0+1 = 1; (B) 1+1 = 2; (C) 2+1 = 3; (D) 2+2 = 4; (E) 2+3 = 5; (F) 4+2 = 6; (G) 4+3 = 7; (H) 4
+4 = 8.
https://doi.org/10.1371/journal.pone.0244886.g001

serial CXRs. Using the highest CXR-SS reduces heterogeneity, as it gives us a set standard of
the maximum pulmonary involvement as seen on CXR to compare patients’ outcomes against.

Statistical analysis
All analyses were performed on IBM SPSS v. 21. Continuous data was presented as mean and
standard deviation, and compared using independent sample t-tests. CXR Severity Scores
were compared using Mann-Whitney U-Tests. Categorical data was presented as frequencies
and percentages, and compared using Chi-squared tests. Spearman’s correlations were used to
investigate the correlations of continuous variables with CXR-SS. Univariate and multivariable
logistic regression was performed with the dependent variables being initial CXR result (positive), initial CXR-SS (5–8), mortality, and ICU-Int. The multivariable models included age,
gender, and variables with a p-value < 0.25 on univariate analysis. A p-value < 0.05 was considered significant for all analyses.

Results
A total of 150 patients were included in this study, with the majority being male (76.7%). The
mean age was 56.1 years, with ages ranging from 23–83 years. The commonest comorbids in
our patients were hypertension (HTN: 46.7%) and diabetes mellitus (T2DM: 37.3%). A positive initial CXR result (CXR Severity Score > 0) was seen in 120 (80%) of patients. The mean
initial CXR-SS was 3.32 ± 2.53. The majority of patients were admitted to the hospital (96%),
and amongst these 30.6% were admitted to the ICU and intubated. While 72.2% of patients
were healthy on discharge, 11.1% left without medical advice or were discharged on request. A
mortality rate of 16.7% was observed in admitted patients. Patients with a positive initial CXR
result were significantly older than those with a negative initial CXR result (58.5 ± 13.75 years
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vs. 46.5 ± 17.13 years; p = 0.001), and also had a significantly greater highest CXR-SS
(5.41 ± 2.23 vs. 2.39 ± 2.86; p < 0.001). Additionally, a significantly higher percentage of
patients with positive initial CXR results were admitted in the ICU and intubated, as compared
to those with negative initial CXR (34.5% vs. 14.3%; p = 0.037). The initial CXR-SS was also
the highest CXR-SS in 56% of patients, while the highest CXR-SS of the remaining patients
was seen on subsequent serial CXRs. In our study, 15 (10%) of patients were labeled with the
code “do-not-resuscitate” (DNR), whilst the rest were labeled full-code. Amongst the patients
labeled DNR, 10 (66.7%) expired and 3 (20%) were discharged on request/left against medical
advice. The patients labeled DNR had a significantly greater mean age (63.40 ± 15.47 years vs.
55.32 ± 14.84 years; p = 0.049), initial CXR-SS (5.00 ± 2.56 vs. 3.19 ± 2.47; p = 0.008), and highest CXR-SS (6.87 ± 1.64 vs. 4.59 ± 2.64; p < 0.001) than those labeled full code. Details of
patients’ demographics and hospital course are shown in Table 1.
Males had a significantly greater highest CXR-SS than females (4.98 ± 2.66 vs. 3.83 ± 2.62;
p = 0.023), as well as a higher mortality rate, though this was not statistically significant (20%
vs. 5.9%; p = 0.054).
The majority of patients had an initial CXR-SS between 0–4 (69.3%), whereas 52% of patients
had a highest CXR-SS between 5–8. On initial CXR, the vast majority of patients showed bilateral
(92%) infiltrates, and these were peripherally located in 81.3% of patients. Infiltrates on initial
CXR were most commonly located in the lower zone (72%) and showed features of consolidations
(80%). The radiographic features of patients in our study are shown in Table 2.
Table 1. Association of patients’ characteristics and hospital course with initial CXR result.
Variable

Overall (N = 150) n (%)/Mean ± SD

Initial CXR Result

P-Value

Positive (N = 120) n (%)/Mean ± SD

Negative (N = 30) n (%)/Mean ± SD

56.1 ± 15.21

58.5 ± 13.75

46.5 ± 17.13

0.001

Male

115 (76.7)

94 (78.3)

21 (70.0)

0.334

Female

35 (23.3)

26 (21.7)

9 (30.0)

Highest CXR-SS

4.71 ± 2.68

5.41 ± 2.23

2.39 ± 2.86

< 0.001

HTN

70 (46.7)

59 (49.2)

11 (36.7)

0.220

T2DM

56 (37.3)

48 (40.0)

8 (26.7)

0.177

CKD

7 (4.7)

7 (5.8)

0 (0)

0.346

Malignancy

1 (0.7)

1 (0.8)

0 (0)

> 0.999

Positive

141 (94.0)

113 (94.2)

28 (93.3)

> 0.999

Negative

9 (6.0)

7 (5.8)

2 (6.7)

Yes

41 (27.3)

35 (29.2)

6 (20.0)

No

109 (72.7)

85 (70.8)

24 (80.0)

144 (96.0)

116 (96.7)

28 (93.3)

Age (years)
Gender

Initial RT-PCR

CT Done
0.314

Admission Status
Inpatient
Outpatient

6 (4.0)

4 (3.3)

2 (6.7)

N = 144

N = 116

N = 28

44 (30.6)

40 (34.5)

4 (14.3)

100 (69.4)

76 (65.5)

24 (85.7)

N = 144

N = 116

N = 28

Recovered

104 (72.2)

81 (69.8)

23 (82.1)

LAMA/DOR

16 (11.1)

13 (11.2)

3 (10.7)

Mortality

24 (16.7)

22 (19.0)

2 (7.1)

10.55 ± 7.83

10.71 ± 7.65

9.89 ± 8.89

ICU with Intubation
Yes
No
Outcome

LOS (days)

0.345
0.037

0.252

0.625

https://doi.org/10.1371/journal.pone.0244886.t001
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Compared to those with an initial CXR-SS 0–4, patients with an initial CXR-SS 5–8 had a
significantly greater highest CXR-SS (6.96 ± 1.17 vs. 3.72 ± 2.56; p < 0.001), a higher rate of
ICU-Int (48.9% vs. 22.2%; p = 0.001), and a higher mortality rate (28.9% vs. 11.1%; p = 0.008).
Compared to those with a highest CXR-SS 0–4, patients with a highest CXR-SS 5–8 were significantly more likely to be male (84.6% vs. 68.1%; p = 0.017) and have diabetes (46.2% vs. 27.8%;
p = 0.020), and had a significantly higher rate of ICU-Int (44.2% vs. 14.9%; p < 0.001), mortality
(24.4% vs. 6.9%; p = 0.004), and hospital LOS (12.26 ± 8.36 vs. 8.58 ± 6.84; p = 0.005). The
ICU-Int and mortality rates according to CXR Severity Scores are shown in Fig 2.

Comorbids, CXR severity score and clinical outcomes
Compared to patients without diabetes, a significantly greater percentage of patients with diabetes underwent ICU-Int (43.6% vs. 22.5%; p = 0.007) and suffered mortality (27.3% vs. 10.1%;
p = 0.007). Moreover, patients with diabetes also had a significantly greater age (62.6 ± 11.42
years vs. 52.2 ± 15.90 years; p < 0.001), initial CXR-SS (3.96 ± 2.52 vs. 2.94 ± 2.47; p = 0.015),
highest CXR-SS (5.70 ± 2.13 vs. 4.13 ± 2.81; p < 0.001), and hospital LOS (12.53 ± 8.81 days vs.
9.33 ± 7.03 days; p = 0.025), compared to patients without diabetes.
Patients with hypertension had a significantly greater age (62.5 ± 12.19 years vs. 50.46 ±
15.42 years; p < 0.001), highest CXR-SS (5.31 ± 2.31 vs. 4.19 ± 2.89; p = 0.010), and hospital
LOS (12.06 ± 8.44 days vs. 9.16 ± 7.11; p = 0.012), compared to patients without hypertension.

Spearman’s correlation of CXR Severity Scores (CXR-SS)
Initial CXR-SS demonstrated a weak but significant positive correlation with age (r = 0.203;
p = 0.013), while the highest CXR-SS also demonstrated a weak but significant positive correlation with age (r = 0.211; p = 0.010) in addition to a moderate positive correlation with hospital
LOS (r = 0.324; p < 0.001).
Table 2. Characteristics of radiographic findings.
Radiological Properties

Overall (N = 150)
n (%)

Initial CXR-SS Category
0–4

104 (69.3)

5–8

46 (30.7)
Highest CXR-SS Category

0–4

72 (48.0)

5–8

78 (52.0)
Initial CXR Laterality

Unilateral

12 (8.0)

Bilateral

138 (92.0)
Initial CXR Centrality

Central

28 (18.7)

Peripheral

122 (81.3)
Initial CXR Zonal Location

Lower

108 (72.0)

Lower and Middle

27 (18.0)

Diffuse

15 (10.0)
Initial CXR Type of Infiltrates

Alveolar/Interstitial
Consolidations

30 (20.0)
(80.0)

https://doi.org/10.1371/journal.pone.0244886.t002
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Fig 2. Patient outcomes according to initial and highest Chest X-Ray Severity Score (CXR-SS). ED: Emergency Department; ICU-Int: ICU Admission with
Intubation; RT-PCR: reverse transcriptase polymerase chain reaction.
https://doi.org/10.1371/journal.pone.0244886.g002

Regression analysis for initial and highest CXR results (Table 3)
On univariate analysis, a positive initial CXR was associated with age (OR: 1.053 [95% CI:
1.022–1.085]) and ICU-Int (3.158 [1.025–9.733]). On multivariable analysis, only age was
independently associated with a positive initial CXR (1.048 [1.014–1.083]).
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Table 3. Regression analyses for initial and highest CXR results.
Variable

3A. Initial CXR Positive
cOR [95% CI]

P-Value

aOR [95% CI]

P-Value

1.053 [1.022–1.085]

0.001

1.048 [1.014–1.083]

0.005

1.724 [0.695–4.276]

0.240

1.474 [0.555–3.919]

0.437

Reference

-

Reference

-

1.703 [0.692–4.188]

0.246

0.845 [0.303–2.354]

0.747

ICU with Intubation

3.158 [1.025–9.733]

0.045

2.085 [0.585–7.427]

0.257

Mortality

3.043 [0.671–13.790]

0.149

1.183 [0.214–6.527]

0.847

Age (years)
Gender
Male
Female
T2DM

Variable

3B. Initial CXR-SS 5–8
cOR [95% CI]

P-Value

aOR [95% CI]

P-Value

1.020 [0.995–1.045]

0.120

1.006 [0.978–1.034]

0.681

2.036 [0.812–5.106]

0.130

1.764 [0.673–4.626]

0.249

Reference

-

Reference

-

T2DM

1.673 [0.816–3.429]

0.160

1.207 [0.538–2.703]

0.648

ICU with Intubation

3.348 [1.578–7.105]

0.002

2.532 [1.109–5.782]

0.027

Mortality

3.250 [1.323–7.987]

0.010

1.765 [0.638–4.881]

0.274

Age (years)
Gender
Male
Female

Variable

3C. Highest CXR-SS 5–8
cOR [95% CI]

P-Value

aOR [95% CI]

P-Value

1.020 [0.998–1.043]

0.078

1.004 [0.978–1.030]

0.756

2.648 [1.190–5.891]

0.017

2.426 [1.027–5.731]

0.043

Reference

-

Reference

-

T2DM

1.958 [0.983–3.901]

0.056

1.442 [0.659–3.155]

0.360

ICU with Intubation

4.507 [2.008–10.117]

< 0.001

3.386 [1.405–8.159]

0.007

Mortality

4.062 [1.424–11.587]

0.009

1.807 [0.560–5.827]

0.322

Age (years)
Gender
Male
Female

https://doi.org/10.1371/journal.pone.0244886.t003

On univariate analysis, initial CXR-SS 5–8 was associated with ICU-Int (3.348 [1.578–
7.105]) and mortality (3.250 [1.323–7.987]). However, on multivariable analysis, only ICU-Int
was independently associated with an initial CXR-SS 5–8 (2.532 [1.109–5.782]).
On univariate analysis highest CXR-SS 5–8 was associated with male gender (2.648 [1.190–
5.891]), ICU-Int (4.507 [2.008–10.117]), and mortality (4.062 [1.424–11.587]). On multivariable analysis, however, CXR-SS 5–8 was independently associated with male gender (2.426
[1.027–5.731]) and ICU-Int (3.386 [1.405–8.159]).

Regression analysis for mortality and ICU admission with intubation
(Table 4)
On univariate logistic regression for mortality, age (1.063 [1.024–1.104]), initial CXR-SS
(1.350 [1.119–1.628]), highest CXR-SS (1.406 [1.130–1.750]), T2DM (3.333 [1.343–8.276]) and
ICU-Int (8.365 [3.143–22.265]) were associated with mortality. On multivariable logistic
regression, age (1.060 [1.009–1.113]), initial CXR-SS (1.278 [1.010–1.617]) and ICU-Int (5.047
[1.731–14.710]) were found to be independent predictors of mortality.
On univariate logistic regression for ICU-Int, age (1.039 [1.012–1.067]), initial CXR-SS
(1.328 [1.139–1.548]), highest CXR-SS (1.460 [1.224–1.742]), T2DM (2.671 [1.288–5.538]) and
LOS (1.078 [1.029–1.129]) were associated with mortality. On multivariable logistic regression,
initial CXR-SS (1.355 [1.136–1.616]) and highest CXR-SS (1.390 [1.143–1.690]) were found to
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Table 4. Regression analyses for mortality and ICU admission with intubation.
Variable

Mortality
cOR [95% CI]

P-Value

aOR [95% CI]

P-Value

1.063 [1.024–1.104]

0.001

1.060 [1.009–1.113]

0.021

4.000 [0.890–17.981]

0.071

4.011 [0.762–21.108]

0.101

Reference

-

Reference

-

Initial CXR-SS

1.350 [1.119–1.628]

0.002

1.278 [1.010–1.617]

0.041

Highest CXR-SS

1.406 [1.130–1.750]

0.002

1.250 [0.964–1.621]

0.092

T2DM

3.333 [1.343–8.276]

0.009

1.763 [0.484–6.417]

0.390

HTN

2.037 [0.827–5.017]

0.112

1.096 [0.279–4.313]

0.895

ICU with Intubation

8.365 [3.143–22.265]

< 0.001

5.047 [1.731–14.710]

0.003

Age (years)
Gender
Male
Female

Variable

ICU Admission with Intubation
cOR [95% CI]

P-Value

aOR [95% CI]

P-Value

1.039 [1.012–1.067]

0.005

1.031 [0.999–1.064]

0.058

1.581 [0.651–3.838]

0.311

1.149 [0.425–3.107]

0.785

Reference

-

Reference

-

1.328 [1.139–1.548]

< 0.001

1.355 [1.136–1.616]

0.001

Highest CXR-SS

1.460 [1.224–1.742]

< 0.001

1.390 [1.143–1.690]

0.001

T2DM

2.671 [1.288–5.538]

0.008

1.520 [0.661–3.495]

0.324

LOS (days)

1.078 [1.029–1.129]

0.002

1.082 [1.026–1.142]

0.003

Age (years)
Gender
Male
Female
Initial CXR-SS

https://doi.org/10.1371/journal.pone.0244886.t004

be an independent predictor of ICU-Int. A longer LOS was also independently associated with
ICU-Int (1.082 [1.026–1.142]).

Discussion
Early prognostication of disease remains a prevailing challenge in the ongoing COVID-19
pandemic, especially in developing countries where healthcare resources are limited. Previously published data from China and the developed world has highlighted the potential role of
imaging in the early identification and prognostication of COVID-19 [11, 13–15]. In this
study, we described the experience of CXR imaging in patients with COVID-19 at a tertiary
care hospital in Pakistan, and explored the association of a CXR-SS proposed by Wong et al.
[11] with clinical outcomes such as ICU admission with intubation (ICU-Int) and mortality.
Though previous studies have assessed the value of various CXR scoring systems in the management of patients with COVID-19 [11, 13–15], to the best of our knowledge this is the first
study done using a CXR-SS adapted from the RALE score in prognostication of clinical outcomes of COVID-19 patients.
The majority of patients in our study had bilateral, peripheral disease with predominantly
lower lobe distribution, with consolidation being the prominent feature, on initial CXR. This
pattern of findings has been demonstrated previously [6, 16]. Lymphadenopathy, pleural effusion and pneumothorax were infrequent findings in our study. On initial CXR, the majority
(69.3%) of patients had a CXR-SS between 0–4. However, 52% of patients’ highest CXR-SS
ranged from 5–8.
On multivariable logistic regression, a positive initial CXR (CXR-SS > 0) was associated
with greater age (OR: 1.060 [95% CI: 1.009–1.113]), while initial CXR-SS 5–8 was associated
with ICU-Int (2.532 [1.109–5.782]). Moreover, initial CXR-SS was also found to be an independent predictor of both ICU-Int (1.355 [1.136–1.616]) and mortality (1.278 [1.010–1.617]).
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Patients’ highest CXR-SS was also identified as a predictor of ICU-Int (1.390 [1.143–1.690]),
with a highest CXR-SS 5–8 also being associated with the male gender (2.426 [1.027–5.731]).
Thus, the CXR-SS system used in our study appeared to show a strong relationship with clinical outcomes, with greater CXR-SS being associated with ICU-Int (initial and highest CXR-SS)
and mortality (initial CXR-SS). Moreover, ICU-Int was independently associated with a longer
length of hospital stay (1.082 [1.026–1.142]). Other independent predictors of mortality
included patient age (1.060 [1.009–1.113]) and ICU-Int (5.047 [1.731–14.710]). A study by
Borghesi et al. similarly found that their self-designed CXR severity score (named the Brixia
score) was independently associated with mortality [13, 14]. Toussie et al. similarly reported
that their CXR severity score predicted hospital admission and intubation [15]. Additionally,
the independent association of CXR-SS 5–8 with male gender in our study is also in line with
observations whereby males are found to be disproportionately affected by COVID-19 [17].
The findings of our study, when taken in consideration collectively, hold particular relevance
for resource-constrained countries such as Pakistan, where a longer length of hospital stay
translates into additional expenses for the patient. The CXR-SS is useful as it is easily reproducible, and enables radiologists to provide treating physicians with understandable quantitative
information regarding the extent of pulmonary infection. However, further studies with larger
patient samples are required to validate the CXR-SS as a tool for prognostication in COVID19.
Limitations of this study include the retrospective nature of its design, and the relatively
small sample size. However, observer bias was addressed by blinding the radiologists to the
diagnosis and clinical condition of the patient. Furthermore, findings on initial CXR were variable due to a heterogeneity in duration of symptoms and infection upon presentation to the
hospital’s emergency department. Moreover, as portable CXRs were used, positioning and
other exposure-related factors may confound CXR findings. Lastly, this study did not contain
a control group of patients (COVID-19 negative) to compare CXR findings and CXR-SS with.

Conclusion
The chest x-ray severity scoring (CXR-SS) system used in this study is a valuable method of
disease prognostication in COVID-19, as initial and highest subsequent CXR-SS show strong
association with ICU admission and mortality. The benefits of this CXR-SS lie in its reproducibility, ability to convey easily understandable objective information between radiologist and
treating physician, and feasibility in resource-constrained settings. While the results of our
study serve as an initial step towards the validation of the CXR-SS as a prognosticative tool,
further studies with larger samples are warranted in this regard.
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